MedTrace Logo

The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience

NCT02454322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-05-05

No results posted yet for this study

Summary

Magnesium is sometimes used to prevent seizures in the setting of hypertensive disorders of pregnancy. The primary aim of this study is to determine if women who receive magnesium are less likely to experience postpartum depression. Other aims include examining the relationship between receiving magnesium and cognitive function and birth experience.

Conditions

  • Depression, Postpartum

Interventions

DRUG

Magnesium Sulfate

Standard of care Magnesium Sulfate given to women with a diagnosis of a hypertensive disorder of pregnancy.

Sponsors & Collaborators

Principal Investigators

  • Emily S. Miller, MD, MPH · Northwestern University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2020-11-30
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02454322 on ClinicalTrials.gov